Last edition
News about
Nona Biosciences Signs License Deal with AstraZeneca for Monoclonal Antibody Development
Nona Biosciences has signed a license deal with AstraZeneca for preclinical monoclonal antibodies that will be used to create targeted therapies in oncology.
Sun Pharma Inaugurates New Plant in Bangladesh
Sun Pharmaceuticals Ltd. has launched a new manufacturing plant at Meghna Industrial Economic Zone in Narayanganj, Bangladesh.
SSI Mantra Hits New Milestone with 100 Successful Robotic Cardiac Surgery
SS Innovations has recently announced that 100 robotic cardiac surgery procedures have been successfully performed with the company’s SSI Mantra Surgical Robotic System.
Global Group Introduces Innovative Salivary Testing Pilot to Combat Oral Health Disparities
Global Group, Inc., in a strategic alliance with technology partner Oral Genome, announce an innovative program aimed at tackling global oral health disparities.
YS Biopharma Announces Name Change to LakeShore Biopharma
The name change and trading symbol change will not affect any rights of shareholders or the Company's operations and financial position. The Company's ordinary shares and warrants will continue to be listed on the Nasdaq.
Biossmann Appoints Pankaj Kedia as Chief AI Officer to Drive Global Expansion and Innovation
Kedia, a renowned technology industry executive and AI thought-leader, joins Biossmann to spearhead its global expansion and drive innovation, positioning the company as a powerhouse in medical solutions.
Indica Labs and Hamamatsu Photonics Receive FDA Clearance for HALO AP Dx Digital Pathology Platform
HALO AP Dx is indicated for the primary diagnosis of surgical pathology slides prepared from formalin-fixed paraffin-embedded (FFPE) tissue scanned by the NanoZoomer® S360MD Slide scanner.
DelSiTech Enters into Licensing Deal with Global Pharma Firm for Drug Delivery
DelSiTech Ltd. has entered into a Licensing Agreement with an undisclosed global pharmaceutical company.
Cipla Gets Final FDA Approval for Lanreotide Injection
Cipla Ltd. has received the final approval for its Abbreviated New Drug Application (ANDA) for Lanreotide Injection 120 mg/0.5 mL, 90 mg/0.3 mL, 60 mg/0.2 mL from the United States Food and Drug Administration (US FDA).
Gland Pharma Reports Remarkable Q4FY24 and FY24 Financial Performance
Gland Pharma Ltd. has announced its financial results for the fourth quarter (Q4FY24) and full year (FY24) ended on Mar 31, 2024.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy